The four patients reported by Udwadia and colleagues were resistant to isoniazid, rifampicin, ethambutol, pyrazinamide, and streptomycin — the standard first-line drugs — as well as ofloxacin (Floxin), moxifloxacin (Avelox), kanamycin, amikacin …
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Top 100 Pharmaceutical Enterprises and the Listed Company SZ.002020